DW
At a glance
Registered since
2024
Senate LDA system
Clients
25
last 3 years
Filings
79
6 agencies contacted
Activity
filings by quarter
Works on
Health Issues 68Medicare/Medicaid 43Budget/Appropriations 24Veterans 12Defense 9Taxation/Internal Revenue Code 9Trade (domestic/foreign) 8Financial Institutions/Investments/Securities 7Copyright/Patent/Trademark 6Medical/Disease Research/Clinical Labs 6Pharmacy 6Manufacturing 3Government Issues 3Transportation 3Consumer Issues/Safety/Products 3
Specific issues
Issues related to alternative treatments for PTSD and research in treating behavioral health challenges.
Issues related to financial services and tax.
Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA certification process; Issues related to Pharmacy Benefit Managers.
Issues related to pharmacies, pharmacists, and Medicare reimbursement; Issues related to Covid funding; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers.
Healthcare initiatives related to novel antibody technology platform.
Issues related to biopharmaceutical research, development, and manufacturing for infectious disease products.
Clients
Filing history
LYKOS THERAPEUTICS
LYKOS THERAPEUTICS
LYKOS THERAPEUTICS
OPTIONS CLEARING CORPORATION (OCC)
VIR BIOTECHNOLOGY, INC.
GLOBAL MEDICAL RESPONSE
GENENTECH
WALGREENS CO.
CYTOVALE, INC.
NOVARTIS, INC.
HEALTHY.IO (US), INC.
GILEAD SCIENCES, INC.